multiple sclerosis

noun

Pathology.

1. a chronic degenerative, often episodic disease of the central nervous system marked by patchy destruction of the myelin that surrounds and insulates nerve fibers, usually appearing in young adulthood and manifested by one or more mild to severe neural and muscular impairments, as spastic weakness in one or more limbs, local sensory losses, bladder dysfunction, or visual disturbances.

multiple sclerosis

noun

1. Also called: disseminated sclerosis. a chronic progressive disease of the central nervous system characterized by loss of some of the myelin sheath surrounding certain nerve fibres and resulting in speech and visual disorders, tremor, muscular incoordination, partial paralysis, etc

multiple sclerosis

1. A chronic degenerative disease of the central nervous system in which gradual destruction of myelin occurs in the brain or spinal cord or both, interfering with the nerve pathways and causing muscular weakness, loss of coordination, and speech and visual disturbances. It occurs chiefly in young adults and is thought to be caused by a defect in the immune system that may be of genetic or viral origin.

multiple sclerosis

1. A chronic disease of the central nervous system characterized by the hardening of patches of tissue in the brain and spinal cord. The cause of this disease has to do with damage to the sheathes of nerves, and there is no specific treatment. It occurs in varying degrees of severity and, in the worst case, can result in permanent paralysis.

Word History and Origins

Origin of multiple sclerosis¹

First recorded in 1880–85

Example Sentences

Since New Jersey resident Natalie Jeremias, 50, was diagnosed with multiple sclerosis earlier this year, she has struggled with getting treatments because of insurance denials and high deductibles.

Read more on The Wall Street Journal

She currently receives disability benefits due to a multiple sclerosis diagnosis.

Read more on Salon

Given adverse events seen with other trials, expectations for fenebrutinib in relapsing multiple sclerosis were modest, he says.

Read more on The Wall Street Journal

And 1994 winners M People donated their prize to a multiple sclerosis charity after a friend was diagnosed with the condition.

Read more on BBC

The Swiss pharmaceutical group said Monday that fenebrutinib met its primary endpoint in a Phase 3 clinical trial in patients with relapsing multiple sclerosis, the most common form of the disease.

Read more on The Wall Street Journal